Curis
CRIS
#11058
Rank
A$6.81 M
Marketcap
A$0.72
Share price
1.73%
Change (1 day)
-58.87%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -A$11.74 Million

According to Curis's latest financial reports the company's current earnings are A$4.31 Million. In 2025 the company made an earning of -A$8.1 Million, an increase over its 2024 earnings that were of -A$64.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$11.74 Million44.94%
2025 -A$8.1 Million-87.38%
2024 -A$64.17 Million-5.77%
2023 -A$68.1 Million-13.1%
2022 -A$78.36 Million27.52%
2021 -A$61.46 Million65.09%
2020 -A$37.23 Million-9.1%
2019 -A$40.95 Million-4.73%
2018 -A$42.98 Million-41.95%
2017 -A$74.04 Million-14.37%
2016 -A$86.46 Million3.55%
2015 -A$83.49 Million271.52%
2014 -A$22.48 Million76.64%
2013 -A$12.73 Million
2011 -A$10.81 Million27.76%
2010 -A$8.46 Million-43.87%
2009 -A$15.07 Million-23.44%
2008 -A$19.69 Million56.66%
2007 -A$12.57 Million-16.71%
2006 -A$15.09 Million-36.92%
2005 -A$23.92 Million156.25%
2004 -A$9.34 Million-37.24%
2003 -A$14.87 Million-93.34%
2002 -A$0.23 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.45 B-82,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.99 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$92.83 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.59 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.49 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$33.4 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.3 Billion 2,203.50%๐Ÿ‡บ๐Ÿ‡ธ USA